What does progression mean for Colorectal Cancer and what happens next
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Progression in Colorectal Cancer
I'm glad you're asking about this—understanding what progression means will help you have better conversations with your care team.
What "Progression" Means
Progression in colorectal cancer means the cancer is growing or spreading despite treatment. This can happen in different ways:
- Local progression: The cancer grows back in or near the original tumor site in the colon
- Regional progression: Cancer spreads to nearby lymph nodes that weren't previously involved
- Distant progression: Cancer spreads to distant organs (liver, lungs, peritoneum/abdominal lining, or other sites)
- Biochemical progression: Blood markers like CEA (carcinoembryonic antigen) rise, suggesting cancer activity even before imaging shows changes
How Doctors Detect Progression
According to NCCN Guidelines for Colon Cancer, your care team monitors for progression through:
- Physical exams every 3-6 months (depending on your stage)
- CEA blood tests every 3-6 months for the first 2 years, then every 6 months for up to 5 years
- CT scans of chest, abdomen, and pelvis (C/A/P CT) on a regular schedule
- Colonoscopy to check for local recurrence
- PET-CT scans if there are concerning findings that need clarification
What Happens Next After Progression Is Detected
The next steps depend on several factors:
Step 1: Comprehensive Evaluation
Your oncology team will determine:
- Where the cancer has progressed (local, regional, or distant)
- How much cancer is present
- Whether it's resectable (can it be surgically removed?)
- Your tumor's molecular characteristics (KRAS, NRAS, BRAF mutations; MMR/MSI status)
Step 2: Treatment Options
According to NCCN Guidelines, treatment approaches vary based on your specific situation:
If cancer is resectable (can be surgically removed):
- Surgery to remove metastases (spread sites) is often preferred
- Local therapies like ablation or radiation for specific lesions
- Chemotherapy before or after surgery (neoadjuvant or adjuvant therapy)
- Preferred chemotherapy regimens include FOLFOX or CAPEOX (combination chemotherapy)
If cancer is unresectable (cannot be surgically removed):
- Systemic chemotherapy (drugs that travel through the bloodstream)
- Biologic therapy - targeted drugs that work based on your tumor's specific mutations:
- Bevacizumab (targets blood vessel growth)
- Cetuximab or panitumumab (target EGFR if your tumor is KRAS wild-type)
- Other targeted therapies depending on specific mutations
- Immunotherapy if your tumor has specific characteristics (dMMR/MSI-H status)
- Clinical trials may offer additional options
If cancer shows signs of conversion potential:
- Your team may use chemotherapy first to shrink the cancer, then reassess for surgery
Step 3: Ongoing Surveillance
Even after treatment for progression, your care team will continue monitoring with:
- Regular imaging and blood work
- Colonoscopy surveillance
- Watch for new areas of progression
Important Questions to Ask Your Oncologist
When progression is detected, these questions can help guide your care:
- Where exactly has the cancer progressed, and what does this mean for my prognosis?
- Is my cancer resectable, and if so, what are the benefits and risks of surgery?
- What are my treatment options, and which do you recommend for my specific situation?
- What is my tumor's molecular profile (KRAS, BRAF, MMR/MSI status), and how does this affect treatment choices?
- Are there clinical trials available that might be appropriate for me?
- What side effects should I expect from the recommended treatment?
- How will we monitor for response to treatment, and how often?
Key Takeaway
Progression doesn't mean the end of treatment options. NCCN Guidelines outline multiple evidence-based approaches depending on your specific situation. The goal shifts to controlling the cancer, managing symptoms, and maintaining quality of life. Your multidisciplinary team (surgeon, medical oncologist, and other specialists) will work together to determine the best approach for YOUR case.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Colon Cancer (2026)Browse all NCCN Guidelines for Patients →Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Use the above evidence to inform your response when relevant. i have no abdominal swelling but a small amount of...
Got it—this is different from visible swelling. A small amount of fluid seen on CT at the end of FOLFIRI treatment is actually fairly common and often
Use the above evidence to inform your response when relevant. ascitis has been mentioned could this be a result of...
Yes, fluid retention can result from FOLFIRI chemotherapy. Here's what's specific to your situation: FOLFIRI and Fluid Retention FOLFIRI a combinat
What can i do to help reduce the fluid retention
Here are evidence-based approaches: Immediate Actions - Elevate legs above heart level when sitting or lying down - Limit salt intake reduces fluid
Fluid retention after chemotherapy course has finished
Fluid retention also called edema—swelling from fluid buildup can happen during or after chemotherapy. Here's what's generally true: Why It Happens